BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25793964)

  • 1. Regulatory B Cells and Mechanisms.
    Rincón-Arévalo H; Sanchez-Parra CC; Castaño D; Yassin L; Vásquez G
    Int Rev Immunol; 2016; 35(2):156-76. PubMed ID: 25793964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
    Kristensen B
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory B cells in anti-tumor immunity.
    Zhang Y; Gallastegui N; Rosenblatt JD
    Int Immunol; 2015 Oct; 27(10):521-30. PubMed ID: 25999597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.
    Wang WW; Yuan XL; Chen H; Xie GH; Ma YH; Zheng YX; Zhou YL; Shen LS
    Oncotarget; 2015 Oct; 6(32):33486-99. PubMed ID: 26378021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis.
    Xing C; Ma N; Xiao H; Wang X; Zheng M; Han G; Chen G; Hou C; Shen B; Li Y; Wang R
    J Leukoc Biol; 2015 Mar; 97(3):547-56. PubMed ID: 25516754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.
    Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M
    J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Number and Function of IL-10-Producing Regulatory B Cells in the Immune Microenvironment at Distinct Stages of Type 1 Diabetes.
    Jiang R; Qin Y; Wang Y; Xu X; Chen H; Xu K; Zhang M
    J Immunol; 2022 Mar; 208(5):1034-1041. PubMed ID: 35140133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal Echinococcus multilocularis infection in mice modulates peritoneal CD4+ and CD8+ regulatory T cell development.
    Mejri N; Müller N; Hemphill A; Gottstein B
    Parasitol Int; 2011 Jan; 60(1):45-53. PubMed ID: 20965274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells in human autoimmune thyroid disease.
    Marazuela M; García-López MA; Figueroa-Vega N; de la Fuente H; Alvarado-Sánchez B; Monsiváis-Urenda A; Sánchez-Madrid F; González-Amaro R
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3639-46. PubMed ID: 16804051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.
    Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M
    Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulatory B cells in human autoimmune diseases].
    Miyagaki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(5):390-7. PubMed ID: 26725860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CD4+CD25+ T regulatory cells in autoimmune diseases.
    Toubi E
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):338-44. PubMed ID: 18092144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IL-21 induces regulatory B cell differentiation and immunosuppressive effect through cognate interaction with T cells].
    Yoshizaki A; Tedder TF
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):57-64. PubMed ID: 25765689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
    Miyagaki T; Fujimoto M; Sato S
    Int Immunol; 2015 Oct; 27(10):495-504. PubMed ID: 25957264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
    Dardalhon V; Awasthi A; Kwon H; Galileos G; Gao W; Sobel RA; Mitsdoerffer M; Strom TB; Elyaman W; Ho IC; Khoury S; Oukka M; Kuchroo VK
    Nat Immunol; 2008 Dec; 9(12):1347-55. PubMed ID: 18997793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
    Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
    Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.